Target Name: Guanylate kinase (isoform b)
NCBI ID: P40449
Review Report on Guanylate kinase (isoform b) Target / Biomarker Content of Review Report on Guanylate kinase (isoform b) Target / Biomarker
Guanylate kinase (isoform b)
Other Name(s): ATP:GMP phosphotransferase | GMP kinase

ISOFORM B: A Potential Drug Target for Cell Signaling and Disease

Guanylate kinase (ISOFORM B) is a protein that is involved in the process of ATP-GMP phosphotransferase. This enzyme is a key player in the regulation of various cellular processes that are critical for proper cell function. Unfortunately, ISOFORM B has also been identified as a potential drug target and has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The protein encoded by the ISOFORM B gene is a 21-kDa protein that is highly conserved across various species. It is a member of the protein kinase superfamily and is characterized by a catalytic active site that is optimized for the transfer of ATP and GTP residues. ISOFORM B is primarily localized to the cytoplasm and is involved in several cellular processes, including cell signaling, DNA replication, and protein synthesis.

ISOFORM B is a critical regulator of the Src tyrosine kinase family, which is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and survival. The Src tyrosine kinase family includes several different isoforms, including ISOFORM A, ISOFORM B, ISOFORM C, and ISOFORM D. These isoforms are involved in the regulation of various cellular processes, including cell signaling, DNA replication, and protein synthesis.

ISOFORM B has been shown to play a role in the regulation of cell signaling, particularly in the regulation of cell proliferation and differentiation. Several studies have shown that ISOFORM B is involved in the regulation of cell cycle progression, including the G1 phase, S-phase, and G2 phase. In addition, ISOFORM B has been shown to play a role in the regulation of cell differentiation and plasticity, including the regulation of cell survival and the regulation of cell proliferation.

ISOFORM B is also involved in the regulation of protein synthesis and has been shown to play a role in the regulation of protein synthesis in various cellular processes. Several studies have shown that ISOFORM B is involved in the regulation of protein synthesis in the regulation of cell signaling, including the regulation of cell growth and the regulation of cell differentiation.

In addition to its role in cell signaling and protein synthesis, ISOFORM B has also been shown to play a role in the regulation of DNA replication. Several studies have shown that ISOFORM B is involved in the regulation of DNA replication, including the regulation of DNA replication in the regulation of cell growth and the regulation of cell differentiation.

Unfortunately, ISOFORM B has also been identified as a potential drug target and has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Several studies have shown that ISOFORM B is involved in the regulation of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

In addition to its role in disease regulation, ISOFORM B is also an attractive drug target due to its unique structure and its involvement in several cellular processes. The catalytic active site of ISOFORM B is optimized for the transfer of ATP and GTP residues, which makes it an attractive target for small molecules. Additionally, ISOFORM B is a 21-kDa protein, which makes it a potential target for small molecules that can be easily synthesized and purified.

In conclusion, ISOFORM B is a protein that is involved in the process of ATP-GMP phosphotransferase and is critical for the regulation of various cellular processes. Unfortunately, ISOFORM B has also been identified as a potential drug target and has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Further research is needed to fully understand the role of ISOFORM B in disease regulation and to develop effective drug treatments.

Protein Name: Guanylate Kinase (isoform B)

The "Guanylate kinase (isoform b) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Guanylate kinase (isoform b) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GUCA1A | GUCA1B | GUCA1C | GUCA2A | GUCA2B | GUCD1 | GUCY1A1 | GUCY1A2 | GUCY1B1 | GUCY1B2 | GUCY2C | GUCY2D | GUCY2EP | GUCY2F | GUCY2GP | GUF1 | GUK1 | GULOP | GULP1 | GUSB | GUSBP1 | GUSBP11 | GUSBP12 | GUSBP14 | GUSBP15 | GUSBP17 | GUSBP2 | GUSBP3 | GUSBP4 | GUSBP5 | GUSBP8 | GVINP1 | GVQW3 | GXYLT1 | GXYLT1P3 | GXYLT1P4 | GXYLT1P6 | GXYLT2 | GYG1 | GYG2 | GYPA | GYPB | GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14